Aurobindo’s Latest Launches Include Truvada And Atripla Rivals

As Company Plans To Broaden Its Injectables Generics Portfolio In China

 
• By Akriti Seth
  
manufacturing facility
Aurobindo is setting up a dedicated manufacturing facility for Europe and the RoW markets in Visakhapatnam India. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin